3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
2
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
2
Conditions
Osteosarcoma
2
Neoplasms, Bone Tissue
1
Interventions
Cyclophosphamide
2040
Radiotherapy
1854
Cisplatin
1820
Carboplatin
1530
Gemcitabine
1432
Paclitaxel
1289
Bevacizumab
1267
Docetaxel
1200
pembrolizumab
1196
Oxaliplatin
1157
Capecitabine
1140
Fluorouracil
1059
Dexamethasone
971
Rituximab
918
Nivolumab
908
Magnetic Resonance Spectroscopy
858
Etoposide
839
Doxorubicin
823
Drug Therapy
789
Radiosurgery
774
Irinotecan
774
Cytarabine
736
fludarabine
714
Leucovorin
674
Lenalidomide
608
fludarabine phosphate
564
Temozolomide
552
Filgrastim
540
Radiation
539
Cetuximab
535
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
mifamurtide
×
Clear all
NCT03643133
2026-05-19
SARCOME13
UNICANCER
Phase 2
Active not recruiting
60 enrolled
NCT02441309
2019-09-13
MEMOS
University of Oxford
Phase 2
Terminated
8 enrolled
17 charts